Januvia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients
Condition:   PDAC - Pancreatic Ductal Adenocarcinoma Intervention:   Drug: Combination of sitagliptin+ gemcitabine + nab-paclitaxel Sponsor:   Tianjin Medical University Cancer Institute and Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 in Healthy Overweight/Obese Volunteers
Condition:   Obesity Interventions:   Drug: K-757;   Drug: K-757 and open-label sitagliptin;   Drug: Matching placebo to K-757;   Drug: Matching placebo to K-757 and matching placebo to K-833;   Drug: K-757 and K-833;   Drug: Matching placebo to K-757, open-label sitagliptin Sponsor:   Kallyope Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2023 Category: Research Source Type: clinical trials